Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mahler

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Critical Care (London, England)|May 29, 2010
Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trialBrent C Opmeer, Kimberly R Boer, Oddeke van Ruler, et al.
Advanced Healthcare Materials|March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesJiwei Cui, Yi Ju, Zachary H Houston, et al.
Rheumatology (Oxford, England)|June 9, 2024
One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitationsMaria A T van Wissen, Cornelia H M van den Ende, Maaike G J Gademan, et al.
Rheumatology International|June 5, 2026
Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trialMaria A T van Wissen, Salima F E van Weely, Cornelia H M van den Ende, et al.
Leukemia|August 20, 2015
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantationT A Seldon, R Pryor, A Palkova, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Oncoimmunology|July 30, 2016
CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesPhillip D Fromm, Michael S Papadimitrious, Jennifer L Hsu, et al.
Lupus|April 20, 2017
The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patientsM Y Choi, A E Clarke, Y St Pierre, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Critical Care (London, England)|May 29, 2010
Costs of relaparotomy on-demand versus planned relaparotomy in patients with severe peritonitis: an economic evaluation within a randomized controlled trialBrent C Opmeer, Kimberly R Boer, Oddeke van Ruler, et al.
Advanced Healthcare Materials|March 15, 2019
Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific AntibodiesJiwei Cui, Yi Ju, Zachary H Houston, et al.
Rheumatology (Oxford, England)|June 9, 2024
One-year effectiveness of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitationsMaria A T van Wissen, Cornelia H M van den Ende, Maaike G J Gademan, et al.
Rheumatology International|June 5, 2026
Cost-utility of long-term exercise therapy in people with axial spondyloarthritis and severe functional limitations: a randomized, controlled trialMaria A T van Wissen, Salima F E van Weely, Cornelia H M van den Ende, et al.
Leukemia|August 20, 2015
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantationT A Seldon, R Pryor, A Palkova, et al.
Leukemia|October 14, 2018
Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaG Fraser, P Cramer, F Demirkan, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Oncoimmunology|July 30, 2016
CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responsesPhillip D Fromm, Michael S Papadimitrious, Jennifer L Hsu, et al.
Lupus|April 20, 2017
The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patientsM Y Choi, A E Clarke, Y St Pierre, et al.
Pageof 20